Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer.
Nanomaterials (Basel)
; 9(4)2019 Apr 18.
Article
in En
| MEDLINE
| ID: mdl-31003512
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Nanomaterials (Basel)
Year:
2019
Document type:
Article
Affiliation country:
Poland